Analysis of the application value of functional status-based personalized nursing in clinical care for acute leukemia

To discuss the functional status-based personalized nursing in clinical care for acute leukemia. 175 patients with acute leukemia were divided into the conventional care group (patients within the group received routine care during chemotherapy for acute leukemia) and the observation group (patients within the group received functional status-based personalized care on the foundation of routine care) according to the method of random number table, and the mental status, quality of life, physical function status and complications during chemotherapy were compared between groups. Compared to the conventional care group following the intervention, the scores of self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were notably decreased in the observation group following the intervention. The scores of quality of life (QOL) and Karl Fischer Physical Functional Status Scale (KPS) were conspicuously increased, and the differences indicate statistical significance (p < 0.05); Compared with the conventional care group, the incidence of infection infectious fever, bleeding and ectopic liver function during chemotherapy in the study group were evidently reduced. The differences are statistically significant (p < 0.05). The functional status-based personalized nursing can effectively improve the mental status and quality of life, promote the physical function status, and effectively decrease the complications during chemotherapy in patients with acute leukemia, which is a safe and effective nursing model.

Acute leukemia; Functional status-based personalized nursing; Mental status; Quality of life; Complication

[1] Pelcovits A, Niroula R. Acute myeloid leukemia: a review. Rhode Island Medical Journal. 2020; 103: 38–40.

[2] Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. The Journal of Clinical Investigation. 2020; 130: 1552–1564.

[3] Alexander TB, Orgel E. Mixed phenotype acute leukemia: current approaches to diagnosis and treatment. Current Oncology Reports. 2021; 23: 22.

[4] Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer Journal. 2021; 11: 41.

[5] Bewersdorf JP, Zeidan AM. Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments? Cells. 2020; 9: 2310.

[6] Khanjani pour-fard-pachekenari A, Rahmani A, Ghahramanian A, Asghari Jafarabadi M, Onyeka TC, Davoodi A. The effect of an oral care protocol and honey mouthwash on mucositis in acute myeloid leukemia patients undergoing chemotherapy: a single-blind clinical trial. Clinical Oral Investigations. 2019; 23: 1811–1821.

[7] Kurtin S. Interdisciplinary management of acute leukemia across the continuum of care. Seminars in Oncology Nursing. 2019; 35: 150953.

[8] Rambaldi A, Ribera J, Kantarjian HM, Dombret H, Ottmann OG, Stein AS, et al. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Cancer. 2020; 126: 304- 310.

[9] Elnaggar RK, Mohamed RR. Aqua-plyometric exercises: potential implications for bone mineral density, functional capacity, and quality of life in survivors of childhood acute lymphoblastic leukemia. Seminars in Oncology Nursing. 2021; 37: 151225.

[10] Heuser M, Ofran Y, Boissel N, Brunet Mauri S, Craddock C, Janssen J, et al. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2020; 31: 697–712.

[11] De Vos J, Baudoux E, Bay J, Calmels B, Cras A, El Cheikh J, et al. Donor lymphocyte infusions (DLI): guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC). Bulletin du Cancer. 2019; 106: S35–S39. (In French)

[12] Yue T, Li Q, Wang R, Liu Z, Guo M, Bai F, et al. Comparison of hospital anxiety and depression scale (HADS) and zung self-rating anxiety/depression scale (SAS/SDS) in evaluating anxiety and depression in patients with psoriatic arthritis. Dermatology. 2020; 236: 170–178.

[13] Lewandowska A, Rudzki G, Lewandowski T, Próchnicki M, Rudzki S, Laskowska B, et al. Quality of life of cancer patients treated with chemotherapy. International Journal of Environmental Research and Public Health. 2020; 17: 6938.

[14] Wang J, Dao FT, Yang L, Qin YZ. Characterization of somatic mutation-associated microenvironment signatures in acute myeloid leukemia patients based on TCGA analysis. Scientific Reports. 2020; 10: 19037.

[15] Zatloukalová S, Azeem K, Čerňan M, Holý O. Epidemiology, risk factors and possibilities for the prevention of acute leukaemia. Epidemiologie, Mikrobiologie, Imunologie. 2021; 70: 208–220.

[16] Qasrawi A, Gomes V, Chacko CA, Mansour A, Kesler M, Arora R, et al. Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database. Leukemia Research. 2020; 89: 106301.

[17] Salarpour F, Goudarzipour K, Mohammadi MH, Ahmadzadeh A, Faraahi S, Allahbakhshian A, et al. Evaluation of growth factor independence 1 expression in patients with de novo acute myeloid leukemia. Journal of Cancer Research and Therapeutics. 2020; 16: 23–27.

[18] Lee H, Park S, Yoon JH, Cho BS, Kim HJ, Lee S, et al. The factors influencing clinical outcomes after leukapheresis in acute leukaemia. Scientific Reports. 2021; 11: 6426.

[19] O’Connor D, Loke J, Brown M, Stanworth SJ, Young A, Prue G. Non-pharmacological supportive-care interventions in acute myeloid leukaemia: a review of randomised controlled trials. British Journal of Haematology. 2021; 195: e97–e113

[20] Boluda B, Martínez-Cuadrón D, Algarra L, Cano I, Sayas MJ, Acuña-Cruz E, et al. Evolving patterns of care and outcomes in relapsed/refractory FLT3 mutated acute myeloid leukemia adult patients. Leukemia & Lymphoma. 2021; 62: 2727–2736.

[21] Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019; 133: 1630–1643.

[22] Yakoub-Agha I, Chabannon C, Bader P, Basak GW, Bonig H, Ciceri F, et al. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Haematologica. 2020; 105: 297–316.

[23] Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, et al. NCCN guidelines insights: acute myeloid leukemia, version 2.2021. Journal of the National Comprehensive Cancer Network. 2021; 19: 16–27.

[24] Brown PA, Shah B, Advani A, Aoun P, Boyer MW, Burke PW, et al. Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2021; 19: 1079–1109.

[25] Gaynon PS, Parekh C. A new standard of care for childhood T-cell acute lymphoblastic leukemia? Pediatric Blood & Cancer. 2021; 68: e29238.

[26] Jensen KS, Klug Albertsen B, Schrøder H, Zalounina Falborg A, Schmiegelow K, Rosthøj S, et al. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study. BMJ Open. 2021; 11: e049847.

[27] Jankowska‐Polańska B, Sliwiński M, Świątoniowska N, Butrym A, Mazur G. Quality of life in children with acute lymphoblastic leukaemia. Scandinavian Journal of Caring Sciences. 2020; 34: 380–389.

[28] Pergolotti M, Sattar S. Measuring functional status of older adults with cancer with patient and performance-based measures, a how-to guide: a young society of geriatric oncology and nursing and allied health initiative. Journal of Geriatric Oncology. 2021; 12: 473–478.

[29] Lin R, Chiang S, Heitkemper MM, Weng S, Lin C, Yang F, et al. Effectiveness of early rehabilitation combined with virtual reality training on muscle strength, mood state, and functional status in patients with acute stroke: a randomized controlled trial. Worldviews on Evidence-Based Nursing. 2020; 17: 158–167.

[30] Albrecht TA, Bryant AL. Psychological and financial distress manage ment in adults with acute leukemia. Seminars in Oncology Nursing. 2019; 35: 150952.